Milestone Pharmaceuticals Inc stock is traded at $0.73, with a volume of 147,843. It is up +5.42% in the last 24 hours and down -4.48% over the past month. Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Previous Close:
$0.6925
Open:
$0.72
24h Volume:
147,843
Relative Volume:
0.17
Market Cap:
$90.88M
Revenue:
$1.78M
Net Income/Loss:
-$68.36M
P/E Ratio:
-
EPS:
-$0.6828
Net Cash Flow:
-$51.59M
1W Performance:
0.00%
1M Performance:
-4.48%
6M Performance:
-62.94%
1Y Performance:
-57.56%
1-Day Range:
$0.7021$0.743
1-Week Range:
$0.6752$0.7999
52-Week Range:
$0.6307$3.06
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
Name
Milestone Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(514) 336-0444Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS